Creating Hope Reauthorization Act

United States116th CongressS-4010Senate
Updated: Jun 18, 2020

Summary

Creating Hope Reauthorization Act This bill permanently reauthorizes a Food and Drug Administration program that awards priority review vouchers to manufacturers of drugs that treat rare pediatric diseases. (A priority review voucher entitles the voucher holder to priority review of a single human drug application.)

Bill texts

Available versions
Introduced (Senate)View official text

1 version available

All available records shown.

Timeline

Latest companion bill action

HR-4439: Creating Hope Reauthorization Act

Received in the Senate.

  1. Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

    Senate

  2. Introduced in Senate

All available records shown.